Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $31.45 | Total: $157.25 |
| 1 | 10 | $26.64 | Total: $266.40 |
| 1 | 25 | $22.57 | Total: $564.25 |
| 1 | 50 | $19.24 | Total: $962.00 |
| 1 | 100 | $16.65 | Total: $1,665.00 |
Overview
CJJ300 is a transforming growth factor-? (TGF-?) inhibitor with an IC50 of 5.3 ?M, disrupting the TGF-?-T?R-I-T?R-II signaling complex and inhibiting cell migration.
Chemical Properties
| Molecular Formula | C30H33N3 |
| Molecular Weight | 435.6 |
| CAS Numbers | 1807631-83-9 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(NC1=CC=CC=C1)C2=C(C)C(CNC3=CC=CC=C3)=C(C)C(CNC4=CC=CC=C4)=C2C |
Storage and Handling
0C Short Term, -20C Long Term
References
Wu H, et al. The development of a novel transforming growth factor-? [TGF-?] inhibitor that disrupts ligand-receptor interactions. Eur J Med Chem. 2020;189 112042.